Add BrightSurf on Google Email

Common antiretroviral drug improves cognition in mouse model of Down syndrome

Researchers found that lamivudine improved cognition in a mouse model of Down syndrome, which could lead to new pharmacological treatments for cognitive impairment. The study highlights the potential of targeting retrotransposons, segments of DNA that contribute to neurodegenerative diseases.

SourceCenter for Genomic Regulation·JournalJournal of Cellular and Molecular Medicine·TypeExperimental study·DateJun 28, 2022